Clinical Trial Update: The Value of 68Ga-FAPI PET/CT for Evaluating Peritoneal Treatment Response [NA]

View source ↗

Summary

This clinical trial update describes evaluating the value of 68Ga-FAPI PET/CT imaging to assess treatment response in peritoneal metastasis, and the study is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Metastasis

Drugs mentioned

• 68Ga-FAPI (gallium-68 labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Peritoneal Metastasis, FAPI | NA | Status: NOT_YET_RECRUITING